HealthCall for the smartphone: technology enhancement of brief intervention in HIV alcohol dependent patients.
HealthCall for the smartphone: technology enhancement of brief intervention in HIV alcohol dependent patients.
复制标题
DOI：
10.1186/1940-0640-9-5
复制
发表时间：
2014-02-17
影响因子：
3.7
通讯作者：
Greenstein E
中科院分区：
文献类型：
--
作者：
Hasin DS;Aharonovich E;Greenstein E
大量饮酒危害艾滋病毒初级保健患者的健康。在艾滋病毒初级保健中的酒精依赖患者中，通过交互式语音应答（HealthCall-IVR）管理的简短干预的技术增强，HealthCall可有效减少大量饮酒。智能手机提供了一个技术平台，以改善健康呼叫。在患者、技术专家和艾滋病诊所工作人员的投入下，我们进一步开发了HealthCall，利用智能手机技术能力（HealthCall-S）。在一项初步研究中，我们比较了41名酒精依赖性HIV感染患者与43名在我们之前的疗效研究中使用HealthCall-IVR的酒精依赖性HIV感染患者的HealthCall-S日常使用率和饮酒结果。两项研究的程序、诊所、人员和措施基本相同，两组患者的人口统计学特征相似（约90%为少数民族）。试点患者使用HealthCall-S的中位数为60天治疗的85.0%，显著高于使用HealthCall-IVR的对照患者的相应比率（63.8%）（p <0.001）。两组中每个饮酒日的平均治疗结束饮酒量相似。患者对HealthCall-S非常满意（即，92%的人表示他们喜欢使用HealthCall-S）。在艾滋病毒初级保健的酒精依赖患者中，通过智能手机提供的HealthCall是可行的，比HealthCall-IVR获得更好的患者参与度，并与减少饮酒有关。在艾滋病毒初级保健环境中，HealthCall-S可以提供一种在短暂干预后改善饮酒结果的方法，通过延长患者的参与时间，对工作人员的时间几乎没有额外的要求。
Heavy drinking jeopardizes the health of patients in HIV primary care. In alcohol dependent patients in HIV primary care, a technological enhancement of brief intervention, HealthCall administered via interactive voice response (HealthCall-IVR) was effective at reducing heavy drinking. The smartphone offered a technology platform to improve HealthCall. Working with input from patients, technology experts, and HIV clinic personnel, we further developed HealthCall, harnessing smartphone technological capacities (HealthCall-S). In a pilot study, we compared rates of HealthCall-S daily use and drinking outcomes in 41 alcohol dependent HIV-infected patients with the 43 alcohol dependent HIV-infected patients who used HealthCall-IVR in our previous efficacy study. Procedures, clinic, personnel, and measures were largely the same in the two studies, and the two groups of patients were demographically similar (~90% minority). Pilot patients used HealthCall-S a median of 85.0% of the 60 days of treatment, significantly greater than the corresponding rate (63.8%) among comparison patients using HealthCall-IVR (p < .001). Mean end-of-treatment drinks per drinking day was similar in the two groups. Patients were highly satisfied with HealthCall-S (i.e., 92% reported that they liked using HealthCall-S). Among alcohol dependent patients in HIV primary care, HealthCall delivered via smartphone is feasible, obtains better patient engagement than HealthCall-IVR, and is associated with decreased drinking. In HIV primary care settings, HealthCall-S may offer a way to improve drinking outcomes after brief intervention by extending patient engagement with little additional demands on staff time.